Eledon Pharmaceuticals, Inc. announced the appointments of David Hovland, Ph.D., as Chief Regulatory Officer and Bryan Smith, J.D., as General Counsel, Corporate Secretary, and Chief Compliance Officer. Dr. Hovland has over 20 years of R&D experience in the pharmaceutical industry, and has contributed to the global development and registration of multiple small and large molecule pharmaceutical products. As Chief Regulatory Officer, he will oversee Eledon’s Regulatory, Quality, and Safety functions. Prior to joining Eledon, Dr. Hovland was Senior Vice President, Global Regulatory Affairs and Quality at Urovant Sciences from April 2018 to April 2021. Prior to joining Eledon, Mr. Smith was General Counsel, Corporate Secretary, and Chief Compliance Officer of Urovant Sciences from April 2018 to April 2021.